 |
2012-01_2016-12 Mechanistic studies on cell cycle and cell division during cell reprograming |
|
2012-01_2012-12 Application of induced pluripotent stem cells in treatment of multiple sclerosis |
|
2012-06_2015-05 Using patient-derived induced pluripotent stem cells for drug screens for efficacy and preclinical predictive toxicology |
|
2013-05_2016-04 Therapeutic potentials of ginsenoside and neural progenitor cell transplantation in stroke |
|
2012-10_2014-04 Therapeutic potentials of a combination of ginsenoside Rd administration and neural progenitor cell transplantation in stroke |
|
2014-01_2016-12 Using patient-specific induced pluripotent stem cells to establish drug screening platforms for neurodegenerative diseases |
|
2016-01_2018-06 Driving metabolite clearance from the brain to maintain its homeostasis via activating the Glymphatic System and exploring its underlying mechanisms |
|
2017-08_2020-07 Mechanistic studies on the development of cerebral small vessel diseases and therapeutic potentials of omega-3 polyunsaturated fatty acids in the treatment of cerebral small vessel diseases and vascular cognition impairment |
|
2017-01_2019-12 Driving metabolite clearance from the brain to maintain its homeostasis via activating the Glymphatic System |
|
2018-01_2020-12 Roles and action mechanisms of SENP3 in autism |
|
2018-09_2021-08 Study of neprilysin gene therapy targeting the glymphatic pathway for the treatment of Alzheimer’s disease and cerebral amyloid angiopathy |
